You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 6, June 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Erythromycin Therapy for Otitis Media With Effusion in Sinobronchial Syndrome

Yukiko lino, MD; Koichi Sugita, MD; Minoru Toriyama, MD; Koichiro Kudo, MD

Arch Otolaryngol Head Neck Surg. 1993;119(6):648-651.


Abstract

• Chronic sinusitis is frequently associated with chronic lower respiratory tract diseases, and the association is referred to as sinobronchial syndrome (SBS). This study was carried out to determine the incidence of otitis media with effusion in the patients with sinobronchial syndrome and to investigate the efficacy of low-dose and long-term erythromycin therapy for otitis media with effusion associated with sinobronchial syndrome. We have found a high incidence of otitis media with effusion in patients with sinobronchial syndrome, the morbidity rate being 54% in 50 cases studied. This ear disease seems to be the major cause of hearing disturbance in patients with sinobronchial syndrome. Sixteen patients with both sinobronchial syndrome and otitis media with effusion were given low-dose and long-term erythromycin therapy (erythromycin base, 600 mg/d for more than 4 months); of these, 13 became effusion-free and most subjects showed improvement in the symptoms of sinobronchial syndrome. The erythromycin therapy thus seems to be exceedingly effective for the treatment of sinobronchial syndrome and associated otitis media with effusion.

(Arch Otolaryngol Head Neck Surg. 1993;119:648-651)



Author Affiliations

From the Department of Otolaryngology (Drs lino, Toriyama, and Sugita) and Division of Respiratory Disease (Dr Kudo), National Medical Center, Tokyo, Japan.


Footnotes

Accepted for publication November 18, 1992.

Reprint requests to Department of Otolaryngology, Teikyo University School of Medicine, Kaga 2-11-1, ltabashi-ku, Tokyo 173, Japan (Dr lino).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Macrolides in cystic fibrosis
Bell et al.
Chronic Respiratory Disease 2005;2:85-98.
ABSTRACT  

Macrolides for the Treatment of Chronic Sinusitis, Asthma, and COPD
Gotfried
Chest 2004;125 :52S-61S.
ABSTRACT | FULL TEXT  

Early Augmentation of Interleukin (IL)-12 Level in the Airway of Mice Administered Orally with Clarithromycin or Intranasally with IL-12 Results in Alleviation of Influenza Infection
Tsurita et al.
J. Pharmacol. Exp. Ther. 2001;298:362-368.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.